Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs
Authors
Keywords
-
Journal
ADDICTION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-16
DOI
10.1111/add.14731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs
- (2019) Sedona Sweeney et al. ADDICTION
- Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison
- (2019) Hannah Fraser et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
- (2018) Jon E. Zibbell et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination
- (2018) Shelley N. Facente et al. PLoS One
- Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services
- (2018) J E Sherbuk et al. Open Forum Infectious Diseases
- HCV reinfection incidence among individuals treated for recent infection
- (2017) M. Martinello et al. JOURNAL OF VIRAL HEPATITIS
- Joint Utility Estimators in Substance Use Disorders
- (2017) Eve Wittenberg et al. VALUE IN HEALTH
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
- (2017) Cecily A. Campbell et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration
- (2016) Marissa M. Maier et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs
- (2016) Amanda Weir et al. DRUG AND ALCOHOL DEPENDENCE
- Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
- (2016) Nick Scott et al. GUT
- Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals
- (2016) Jagpreet Chhatwal et al. HEPATOLOGY
- Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
- (2016) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
- (2016) J. Peveling-Oberhag et al. JOURNAL OF VIRAL HEPATITIS
- HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
- (2016) Philip J. Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population
- (2015) Eve Wittenberg et al. ADDICTION
- Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus
- (2015) Mehdi Najafzadeh et al. ANNALS OF INTERNAL MEDICINE
- Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs
- (2015) Lauren A. Canary et al. ANNALS OF INTERNAL MEDICINE
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus
- (2015) David B. Rein et al. CLINICAL INFECTIOUS DISEASES
- Factors associated with being asked to initiate someone into injection drug use
- (2015) Ricky N. Bluthenthal et al. DRUG AND ALCOHOL DEPENDENCE
- Toward a more accurate estimate of the prevalence of hepatitis C in the United States
- (2015) Brian R. Edlin et al. HEPATOLOGY
- Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
- (2015) Heide Jackson et al. Substance Abuse
- Hepatitis C Screening Trends in a Large Integrated Health System
- (2014) Benjamin P. Linas et al. AMERICAN JOURNAL OF MEDICINE
- Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics
- (2014) Jon E. Zibbell et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012
- (2014) Anil G. Suryaprasad et al. CLINICAL INFECTIOUS DISEASES
- Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
- (2014) Yao-Chun Hsu et al. GUT
- Cost-Effectiveness Uncertainty Analysis Methods
- (2014) Jonathan D. Campbell et al. MEDICAL DECISION MAKING
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis
- (2014) Baligh R. Yehia et al. PLoS One
- Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
- (2014) Judith I. Tsui et al. JAMA Internal Medicine
- Mortality among people who inject drugs: a systematic review and meta-analysis
- (2013) Bradley M Mathers et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention
- (2013) Kimberly Page et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C in the United States
- (2013) Scott D. Holmberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992–2007
- (2013) Barbara Tempalski et al. PLoS One
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care
- (2013) Marija Zeremski WORLD JOURNAL OF GASTROENTEROLOGY
- Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study
- (2012) J. L. Evans et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users
- (2012) Jennifer R. Havens et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence
- (2012) P. R. Spradling et al. CLINICAL INFECTIOUS DISEASES
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
- (2012) Lauren E. Cipriano et al. PLoS One
- Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
- (2012) G. J. MacArthur et al. BMJ-British Medical Journal
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Comparing Respondent-Driven Sampling and Targeted Sampling Methods of Recruiting Injection Drug Users in San Francisco
- (2010) Alex H. Kral et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
- Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection
- (2009) Kimberly Page et al. JOURNAL OF INFECTIOUS DISEASES
- Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS
- (2008) Peter Lawrinson et al. ADDICTION
- Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review
- (2008) Monica Malta et al. ADDICTION
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started